Showing 5,171 results

Filters Content type: Editors' picks Country: United States
HIV & criminal law

Want to Prove You Disclosed Your HIV Status? Here's an App for That

Editor's pick
Poz magazine news
24 September 2015
Pharmaceutical industry

Why the 5000% price hike for pyrimethamine in the US is relevant in the UK

Editor's pick
HIV i-Base
24 September 2015
Changing treatment

New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq® Maintains HIV Viral Suppression

Editor's pick
Viiv Healthcare press release
23 September 2015
Combatting stigma

Motorist receives $40,000 settlement after police officer tickets her for having HIV

Editor's pick
The Independent
23 September 2015
Adherence

Can’t Swallow a Pill? There’s Help for That

Editor's pick
New York Times
22 September 2015
Pharmaceutical industry

How an obscure drug’s 4,000% price increase might finally spur action on soaring health-care costs

Editor's pick
Washington Post
22 September 2015
New & experimental HIV treatments

HIV Patients Successfully Reach One Year of Virologic Suppression in PRO 140 Monotherapy Study

Editor's pick
Cytodyn press release
22 September 2015
New & experimental HIV treatments

Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS

Editor's pick
Sangamo press release
22 September 2015
Global health initiatives

Report Shows 17 Million Lives Saved

Editor's pick
Global Fund
22 September 2015
Pharmaceutical industry

Nonprofit Gets Back Drug and Reverses 18-Fold Increase in Price

Editor's pick
Bloomberg
22 September 2015
Pharmaceutical industry

Hedge funder Martin Shkreli buys rights to drug used by HIV patients and raises price from $13.50 to $750 per pill

Editor's pick
The Independent
22 September 2015
Confidentiality, consent & medical ethics

AIDS Healthcare Foundation's Demand for Medical Records Endangers Us All

Editor's pick
The Body
21 September 2015
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir (SOF) and Velpatasvir (VEL) (GS-5816) for the Treatment of All Six Hepatitis C Genotypes

Editor's pick
Gilead press release
21 September 2015
PrEP

Is PrEP 100 % Effective or 100 % Over-Hyped?

Editor's pick
The Body Pro
21 September 2015
New & experimental HIV treatments

Five Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
21 September 2015
The search for a cure

Cancer drug promises to break down barrier to HIV cure

Editor's pick
The Conversation
21 September 2015
Sex workers

Vital new resource on sex work law will help sex workers globally to realise their rights

Editor's pick
Institute of Development Studies press release
18 September 2015
New & experimental hepatitis C treatment

Achillion Reports 100% SVR12 From Second Cohort of Patients in the Previously-Completed Six Week Phase 2 Trial Evaluating Odalasvir (ACH-3102) and Sofosbuvir for Genotype 1 HCV ("Proxy Study")

Editor's pick
Achillion press release
18 September 2015
PrEP

Gay Man Sues After Being Denied Insurance Because of PrEP

Editor's pick
Poz magazine news
18 September 2015
Transgender people

Why Transgender Women Chanted ‘We Are Not Gay Men!’ At An AIDS Conference

Editor's pick
Think Progress
18 September 2015
The search for a cure

U.S. Survey on Willingness to Participate in HIV Cure-Related Research: Your Opinion Matters (US readers only)

Editor's pick
University of North Carolina
16 September 2015
Improving HIV care

San Francisco AIDS Foundation Opens Groundbreaking Health and Wellness Center for Gay and Bi Men

Editor's pick
HIVEqual.org
15 September 2015
Activism & civil society

Gregg Gonsalves: It’s not just the germs

Editor's pick
Yale Alumni Magazine
15 September 2015
Activism & civil society

10 Big Issues Discussed at the United States Conference on AIDS

Editor's pick
Poz
15 September 2015